Efficacy and Safety of First-Line Treatment Strategies for Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Bayesian Network Meta-Analysis

BackgroundTargeted therapies have led to significant improvement in the management and prognosis of anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC). We performed a network meta-analysis of frontline treatment options of ALK-positive NSCLC to provide clinical guidance.Met...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ling Peng, Dafeng Lu, Yang Xia, Shaodong Hong, Giovanni Selvaggi, Justin Stebbing, Yilan Sun, Fei Liang
Format: article
Langue:EN
Publié: Frontiers Media S.A. 2021
Sujets:
ALK
Accès en ligne:https://doaj.org/article/18aa3ed68b5f40cf8eddd12cb3e316ca
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!